Tags

Type your tag names separated by a space and hit enter

Flavonoids. A review of the pharmacology and therapeutic efficacy of Daflon 500 mg in patients with chronic venous insufficiency and related disorders.
Angiology. 1994 Jun; 45(6):419-28.A

Abstract

Daflon 500 mg consists of 450 mg diosmin and 50 mg flavonoid expressed as hesperidin. The authors describe its effects on the microcirculation in chronic venous insufficiency: improvement of venous tone, inhibition of prostaglandin synthesis, protection against free radicals, activation of the complement system, and increased lymphatic drainage. The authors summarize studies of its therapeutic efficacy in reducing venous capacitance, distensibility, and emptying time; reducing capillary permeability; and increasing capillary resistance.

Authors+Show Affiliations

Department of Gastroenterological Surgery, Herlev University Hospital, Copenhagen, Denmark.No affiliation info available

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

8203767

Citation

Struckmann, J R., and A N. Nicolaides. "Flavonoids. a Review of the Pharmacology and Therapeutic Efficacy of Daflon 500 Mg in Patients With Chronic Venous Insufficiency and Related Disorders." Angiology, vol. 45, no. 6, 1994, pp. 419-28.
Struckmann JR, Nicolaides AN. Flavonoids. A review of the pharmacology and therapeutic efficacy of Daflon 500 mg in patients with chronic venous insufficiency and related disorders. Angiology. 1994;45(6):419-28.
Struckmann, J. R., & Nicolaides, A. N. (1994). Flavonoids. A review of the pharmacology and therapeutic efficacy of Daflon 500 mg in patients with chronic venous insufficiency and related disorders. Angiology, 45(6), 419-28.
Struckmann JR, Nicolaides AN. Flavonoids. a Review of the Pharmacology and Therapeutic Efficacy of Daflon 500 Mg in Patients With Chronic Venous Insufficiency and Related Disorders. Angiology. 1994;45(6):419-28. PubMed PMID: 8203767.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Flavonoids. A review of the pharmacology and therapeutic efficacy of Daflon 500 mg in patients with chronic venous insufficiency and related disorders. AU - Struckmann,J R, AU - Nicolaides,A N, PY - 1994/6/1/pubmed PY - 1994/6/1/medline PY - 1994/6/1/entrez SP - 419 EP - 28 JF - Angiology JO - Angiology VL - 45 IS - 6 N2 - Daflon 500 mg consists of 450 mg diosmin and 50 mg flavonoid expressed as hesperidin. The authors describe its effects on the microcirculation in chronic venous insufficiency: improvement of venous tone, inhibition of prostaglandin synthesis, protection against free radicals, activation of the complement system, and increased lymphatic drainage. The authors summarize studies of its therapeutic efficacy in reducing venous capacitance, distensibility, and emptying time; reducing capillary permeability; and increasing capillary resistance. SN - 0003-3197 UR - https://www.unboundmedicine.com/medline/citation/8203767/Flavonoids__A_review_of_the_pharmacology_and_therapeutic_efficacy_of_Daflon_500_mg_in_patients_with_chronic_venous_insufficiency_and_related_disorders_ L2 - https://journals.sagepub.com/doi/10.1177/000331979404500602?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub=pubmed DB - PRIME DP - Unbound Medicine ER -